Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
2. Cita con resumen
Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, de Wit S, Law M, Monforte AD, Friis-Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis 2010;201:318-30. [Ref.ID 87818]
3.Tiene citas relacionadas Cita con resumen
Law M, Wald N. Cholesterol, statins, and mortality. Lancet 2008;371:1161-2. [Ref.ID 82574]
4.Tiene citas relacionadas Cita con resumen
Law M, Wald NJ. Efficacy and safety of cholesterol-lowering treatment. Lancet 2006;367:469-70. [Ref.ID 76162]
Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005;330:1187-8. [Ref.ID 73867]
6.Tiene citas relacionadas Cita con resumen
Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA, for the Rosey investigators. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. Lancet 2004;363:429-38. [Ref.ID 69075]
7.Tiene citas relacionadas
Wald N, Law M, Morris J, Rudnicka A4, Jordan R. "Polypill" to fight cardiovascular disease. Authors' reply. BMJ 2003;327:809-10. [Ref.ID 67735]
8.Tiene citas relacionadas
Wald DS, Law M, Morris J, Wald NJ. Folate and risk of cardiovascular disease. Study results were misinterpreted. BMJ 2003;326:1035-6. [Ref.ID 66272]
9.Tiene citas relacionadas Cita con resumen
Wald N, Law M. MRC/BHF Heart Protection Study. Lancet 2002;360:1781. [Ref.ID 64241]
10.Tiene citas relacionadas
Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-6. [Ref.ID 64179]
11.Tiene citas relacionadas
Law M, Wald NJ. Risk factor thresholds. Authors' reply. BMJ 2002;325:1115. [Ref.ID 64025]
Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA, for the Mitochondrial Toxicity (MITOX) Study Group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy. A randomized trial. JAMA 2002;288:207-15. [Ref.ID 62738]
13.Tiene citas relacionadas Cita con resumen
Wald NJ, Law M, Haddow JE, Craig WY. Apolipoproteins and prediction of fatal myocardial infarction. Lancet 2002;359:1864. [Ref.ID 62195]
14.Tiene citas relacionadas
Law M, Wald NJ. Cholesterol and all-cause mortality in Honolulu. Lancet 2001;358:1904. [Ref.ID 60023]
15.Tiene citas relacionadas
Law M, Hackshaw A, Wald N. Screening mammography re-evaluated. Lancet 2000;355:749-50. [Ref.ID 49581]
16.Tiene citas relacionadas
Law M, Wald N. Authors' response. BMJ 1999;318:1479-80. [Ref.ID 45625]
17.Tiene citas relacionadas Cita con resumen
Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999;318:1471-80. [Ref.ID 45621]
Law M. Commentary: evidence on salt is consistent. BMJ 1996;312:1284-5. [Ref.ID 26794]
20. Cita con resumen
Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995;155:1933-41. [Ref.ID 25214]
Seleccionar todas
 1 a 20 de 23 siguiente >>